Abstract:OBJECTIVE:To assess whether the occurrence of coronary artery lesion was correlated with the changes of endothelial progenitor cell (EPC) number and function in murine model of Kawasaki disease (KD).METHODS:Lactobacillus casei cell wall extract (LCWE) was prepared and then C57BL/6 mice received a single intraperitoneal injection of LCWE for inducing KD. Twenty-four mice were categorized randomly into 3 groups: KD model group at Day 14 post-injection, KD model group at Day 56 post-injection and control group with an intraperitoneal injection of phosphate buffered solution (n = 8 each). The number of circulating EPC was defined as CD34(+)Flk-1(+)CD45(-) from mice. Meanwhile, bone marrow mononuclear cells were cultured in vitro to expand EPC for functional analysis. After 7 days of culturing, EPC were inoculated onto culture plate and thiazolyl blue assay was used to measure the absorbance value by enzyme labeling instrument to evaluate the proliferation. The adhesion of EPC was performed by replating cells on fibronectin coated dishes and then counting the number of adherent cells. The migration of EPC was assayed by Transwell.RESULTS:Focal inflammatory infiltrate was evident in coronary artery trunk and a series of branches at Day 14 post-injection. The inflammatory cell infiltrate consisted of mononuclear lymphocytes. The number of circulating EPC were significantly lower in the Day 14 LCWE-treating murine model versus the controls (0.017% ± 0.008% vs 0.028% ± 0.007%, P < 0.01). Disruption of elastin was consistently observed at Day 56 post-injection. And there was no apparent recovery in number of EPC (0.016% ± 0.007%, P < 0.01). When bone marrow mononuclear cells were cultured in vitro, the colony-forming ability of EPC decreased in the KD model group at Day 14 post-injection versus the controls. Test of proliferating ability showed that the absorbance was 0.39 ± 0.11 in MTT experiment and decreased than the controls (0.61 ± 0.14, P < 0.01). Adhesion and migration were also down-regulated versus the controls ((3.1 ± 0.6) and (3.2 ± 0.6) vs (6.4 ± 1.2) and (6.2 ± 0.5) cells/HPF, both P < 0.01). In the KD model group at Day 56 post-injection, the colony-forming ability of EPC was not recovered significantly. Proliferation ability, adhesion and migration were still decreased compared to the controls (0.38 ± 0.09, (3.12 ± 0.56) cells/HPF and (3.29 ± 0.63) cells/HPF, all P < 0.01).CONCLUSION:The occurrence of coronary artery lesion may be correlated with the down-regulation of EPC number and function in murine model of KD.

Vascular Repair and Anti-Inflammatory Effects of Soluble Epoxide Hydrolase Inhibitor

The Anti-inflammatory Effect of Soluble Epoxide Hydrolase Inhibitor and 14, 15-EET in Kawasaki Disease Through PPARγ/STAT1 Signaling Pathway

The Therapeutic Effects of EFNB2-Fc in a Cell Model of Kawasaki Disease.

Notch4 Signaling Pathway in a Kawasaki Disease Mouse Model Induced by Lactobacillus Casei Cell Wall Extract.

Notch4 Signaling Pathway of Endothelial Progenitor Cells in a Kawasaki Disease Model Induced by Lactobacillus Casei Cell Wall Extract.

Soluble Epoxide Hydrolase Inhibitor, 12-(3-adamantan-1-yl-ureido)-dodecanoic Acid, Represses Human Aortic Smooth Muscle Cell Proliferation and Migration by Regulating Cell Death Pathways Via the Mtor Signaling.

Therapeutic Effects of the Soluble Epoxide Hydrolase (seh) Inhibitor AUDA on Atherosclerotic Diseases.

The role of Ca 2+ /NFAT in Dysfunction and Inflammation of Human Coronary Endothelial Cells induced by Sera from patients with Kawasaki disease

Soluble Epoxide Hydrolase Inhibitor t-AUCB Ameliorates Vascular Endothelial Dysfunction by Influencing the NF-κB/miR-155-5p/eNOS/NO/IκB Cycle in Hypertensive Rats

A potent soluble epoxide hydrolase inhibitor, t-AUCB, acts through PPARγ to modulate the function of endothelial progenitor cells from patients with acute myocardial infarction

Soluble Epoxide Hydrolase: a Promising Therapeutic Target for Cardiovascular Diseases.

[Status of Endothelial Progenitor Cell in Murine Model of Kawasaki Disease].

Soluble Epoxide Hydrolase Inhibition Protected against Angiotensin II-induced Adventitial Remodeling

IL-37b alleviates endothelial cell apoptosis and inflammation in Kawasaki disease through IL-1R8 pathway

Adeno-associated Virus Vector-mediated Interleukin-10 Induction Prevents Vascular Inflammation in a Murine Model of Kawasaki Disease

EETs Mediate Cardioprotection of Salvianolic Acids Through MAPK Signaling Pathway

Ursolic Acid Inhibits NLRP3 Inflammasome Activation and Alleviates Vascular Smooth Muscle Injury in Kawasaki Disease

Abstract 13032: Endothelial Cell Response to Intravenous Immunoglobulin, Infliximab and Atorvastatin Treatment During the Acute Phase of Kawasaki Disease

Soluble epoxide hydrolase inhibition attenuates aortic plaque formation in a murine model of accelerated atherogenesis

Epoxide Metabolites of Arachidonate and Docosahexaenoate Function Conversely in Acute Kidney Injury Involved in GSK3β Signaling

Human adipose tissue-derived stem cells inhibit coronary artery vasculitis in a mouse model of Kawasaki disease